טוען...
State of the art and perspectives in the treatment of glioblastoma
Glioblastoma is the most common malignant primary brain tumor. Cures are rare and median survival varies from several to 22 months. Standard treatment for good performance patients consists of maximal safe surgical resection followed by radiotherapy with concurrent temozolomide (TMZ) chemotherapy an...
שמור ב:
| הוצא לאור ב: | CNS Oncol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6176827/ https://ncbi.nlm.nih.gov/pubmed/25054300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.12.5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|